MODIFICĂRI ECO-MORFOLOGICE ALE ORGANELOR INTERNE LA SUBIECȚII CU AFECȚIUNI ALE GLANDEI TIROIDE POST-COVID-19
MODIFICĂRI ECO-MORFOLOGICE ALE ORGANELOR INTERNE LA SUBIECȚII CU AFECȚIUNI ALE GLANDEI TIROIDE POST-COVID-19
DOI:
https://doi.org/10.52692/1857-0011.2022.2-73.22Cuvinte cheie:
glandă tiroidă, ecomorfologie, perioadă postcovid, afecțiune, organe interneRezumat
COVID-19 este o boală serioasă și agresivă care afectează toate sistemele organismului uman manifestându-se prin diferite complicații, majoritatea de durată (glanda tiroidă, plămânii, ficatul, rinichii, colecistul, sistemul nervos, sistemul organelor genitale, sistemul osos etc.). Pacienții necesită o investigație complexă cu analiza minuțioasă a tuturor investigațiilor efectuate pentru a aplica un tratament mai efectiv, diminuând complicațiile postcovid.
Referințe
НАСОНОВ, Е.Л. Коронавирусная болезнь 2019 (COVID-19): размышления ревматолога. Научно-практическая ревматология. 2020, 58(2), 123-132. doi. org/10.14412/1995-4484-2020-123-132
AL GHAMDI, M., ALGHAMDI, K.M., GHANDOORA, Y. et al. Treatment outcomes for patients with Middle Eastern Respiratory Syndrome Coronavirus (MERS CoV) infection at a coronavirus referral center in the Kingdom of Saudi Arabia. BMC infectious diseases. 2016, 16(1), 174.
AMANN, K., BOOR, P., WIECH, T. et al. COVID-19 effects on the kidney. Pathologe. 2021, 1, 1-5. doi: 10.1007/s00292-020-00900-x.
ASKARI, H., SANADGOL, N., AZARNEZHAD,A. et al. Kidney diseases and COVID-19 infection: causes and effect, supportive therapeutics and nutritional perspectives. Heliyon. 2021, 7(1), e06008. doi: 10.1016/j.heliyon.2021. e06008
BUDI EH, SCHAUB JR, DECARIS M, TURNER S, DERYNCK R. TGF-beta as a driver of fibrosis: Physiological roles and therapeutic opportunities. J Pathol. 2021, 254(4), 358-373. doi: 10.1002/path.5680.
CAPACCIONE, K.M., YANG, H., WEST, E. et al. Pathophysiology and imaging findings of COVID-19 infection: An organ-system based review. Acad Radiol. 2021, 28(5), 595-607. doi: 10.1016/j.acra.2021.01.022
DARIF, D., HAMMI, I., KIHEL, A., EL IDRISSI SAIK, I., GUESSOUS, F., AKARID, K. The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong? Microb Pathog. 2021, 18(153), 104799. doi: 10.1016/j.micpath.2021.104799
DE GIORGIO, M.R., DI NOIA, S., MORCIANO, C., CONTE, D. The impact of SARS-CoV-2 on skeletal muscles. Acta Myol. 2020, 1, 39(4), 307-312. doi: 10.36185/2532-1900-034.
FAN, B.E., CHONG, V.C.L., CHAN, S.S.W. et al. Hematologic parameters in patients with COVID-19 infection. Am J Hematol. 2020, 95(6), E131-E134. doi: 10.1002/ajh.25774.
FERRARA, F., VITIELLO, A. Scientific and pharmacological rationale for the treatment of cardiac damage caused by COVID-19. Discov Med. 2020, 30(161), 155-161.
HIGGINS, V., SOHAEI, D., DIAMANDIS, E.P., PRASSAS, I. COVID-19: from an acute to chronic disease? Potential long-term health consequences. Crit Rev Clin Lab Sci. 2020, 21, 1-23. doi: 10.1080/10408363.2020.1860895.
MARTINS-FILHO, P.R., TAVARES, C.S.S., SANTOS, V.S. Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data. European journal of internal medicine, 76 (2020), 97-99.
MATUIZZI, C., LIPPI, G. Which lessons shall we learn from the 2019 novel coronavirus outbreak? Ann Transl Med. 2020, 8, 48.
MCDONALD, L.T. Healing after COVID-19: are survivors at risk for pulmonary fibrosis? Am J Physiol Lung Cell Mol Physiol. 2021, 320(2), L257-L265. doi: 10.1152/ajplung.00238.2020.
OSTERGAARD, L. SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiol Rep. 2021, 9(3), e14726. doi: 10.14814/phy2.14726.
PLAÇAIS, L, RICHER, Q. COVID-19: caractéristiquescliniques, biologiques et radiologiques chez l’adulte, la femme enceinte et l’enfant. Une mise au point au cœur de la pandémie. Rev Med Interne. 2020, 41, 308-318.
ROSSI, P.G., MARINO, M., FORMISANO, D. et al. Characteristics and outcomes of a cohort of COVID-19 patients in the Province of Reggio Emilia, Italy. PLoS One. 2020, 15(8), e0238281. doi: 10.1371/journal. pone.0238281. eCollection 2020.
SCAPPATICCIO, L., PITOIA, F., ESPOSITO, K. et al. Impact of COVID-19 on the thyroid gland: an update. Rev Endocr Metab Disord. 2020, 1-13. doi: 10.1007/s11154-020-09615-z.
SHCHENDRYGINA, A., NAGEL, E., PUNTMANN, V.O., VALBUENA-LOPEZ, S. COVID-19 myocarditis and prospective heart failure burden. Expert Rev Cardiovasc Ther. 2021, 19(1), 5-14. doi: 10.1080/14779072.2021.1844005.
SPEER, G., SOMOGYI, P. Thyroid complications of SARS and coronavirus disease 2019 (COVID-19). Endocr J. 2021, 68(2), 129-136. doi: 10.1507/endocrj.EJ20-0443.
WANG, K., QIU, Z., LIU, J. et AL. Analysis of the clinical characteristics of 77 COVID-19 deaths. Scientific Reports, 2020, 10, p. 16384.
WU, F., ZHAO, S., YU, B. et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020, 579, 265–269.
ZHANG, C., WU, Z., LI, J.W. et al. Discharge may not be the end of treatment: Pay attention to pulmonary fibrosis caused by severe COVID-19. J Med Virol. 2021, 93(3), 1378-1386. doi: 10.1002/jmv.26634.
Descărcări
Publicat
Număr
Secțiune
Licență
Copyright (c) 2022 Buletinul Academiei de Științe a Moldovei. Științe medicale
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
Această lucrare este licențiată în temeiul Creative Commons Attribution 4.0 International License.